| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |